Antidote Therapeutics, Inc. announced it raised $200,000 in an initial filing from an offering of $200,000

Sep 11, 2017•almost 8 years ago

Amount Raised

$200,000

Round Type

pre-seed

GaithersburgBiotechnology

Company Information

Company

Antidote Therapeutics, Inc.

Location

708 QUINCE ORCHARD ROAD

Gaithersburg, Maryland, United States

About

Antidote Therapeutics, a science-driven biopharmaceutical company focused on developing novel nicotine-blocking therapies to treat diseases caused or worsened by nicotine.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Antidote Therapeutics, Inc. announced it raised $200,000 in an initial filing from an offering of $200,000

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information